Novartis Partners with Generate in $1B Biotech Deal
Novartis and Generate forge $1B+ deal to innovate protein therapeutics using generative AI technology.
- Latest
- Trending
Novartis and Generate forge $1B+ deal to innovate protein therapeutics using generative AI technology.
Explore today's market trends and social media insights affecting NASDAQ.
Explore market movements of US indices and Twitter trends impacting financial decisions.
Explore how social media trends impact market signals and investment strategies as of September 23, 2024.
Ori Biotech and CRL partner to optimize CAR-T production, reducing labor by 70%, costs by 50%, and process time by ...
Vir Biotechnology appoints Jason O’Byrne as CFO, effective October 2, 2024, boosting financial strategy and leadership.
Medera aims for Nasdaq listing via SPAC to boost gene therapies, spotlighting rare biotech SPACs in 2024.
AI in drug discovery market to skyrocket, reaching USD 11,874.24 million by 2032, with a CAGR of 37.5%.
Shanghai Henlius Biotech announces key leadership changes, appointing new secretarial roles to ensure regulatory compliance.
Zydus acquires 50% of Sterling Biotech to enter fermented protein sector, shares fall 6%.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.